- recruitingPHASE2
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age)
This study is testing a new mRNA vaccine called mRNA-1982 to see how safe it is and how well it helps prevent Lyme disease in healthy adults aged 18 to 70. It compares the vaccine to a dummy injection.
Canada - recruiting
LYME-UK – A study of early Lyme disease within GPs in the UK
The LYME-UK study is looking into Lyme disease in the UK. Researchers want to learn more about how many people get it, how it's diagnosed, and what happens to people after treatment. This will help doctors better understand and treat the condition.
United Kingdom · England